A new concise and facile method was explored to synthesize a series of novel chalcone derivatives containing a purine and benzenesulfonamide moiety and their antiviral properties were evaluated against TMV and CMV. Biological assays indicated that several of the derivatives exhibited significant anti-TMV and anti-CMV activities in vivo. In particular, compound d2 displayed excellent inactivating activity against TMV, with the EC50 value of 51.65 μg/mL, which was better than that of ribavirin (150.45 μg/mL). Molecular docking showed that there are four hydrogen bonds between compound d2 and TMV coat protein (TMV-CP). Compound d2 demonstrated strong binding capacity to TMV-CP with Ka = 1.58 × 105 L/mol and Kd = 12.16 μM. These findings indicated that chalcone derivatives are worthy of further research and development as templates for new antiviral agents.
Antiviral properties and interaction of novel chalcone derivatives containing a purine and benzenesulfonamide moiety.
Dagui Zhou,D. Xie,Fangcheng He,B. Song,D. Hu
Published 2018 in Bioorganic & Medicinal Chemistry Letters
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Bioorganic & Medicinal Chemistry Letters
- Publication date
2018-06-01
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-31 of 31 references · Page 1 of 1
CITED BY
Showing 1-84 of 84 citing papers · Page 1 of 1